Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Degeneration Nonexudative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02590692
What this trial is testing

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Who this might be right for
Dry Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 16
Post-approval studies (Phase 4)Active Not RecruitingNCT06970665
What this trial is testing

A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Astellas Pharma Inc 17
Early research (Phase 1)Study completedNCT04615325
What this trial is testing

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 37
Testing effectiveness (Phase 2)Looking for participantsNCT07668804
What this trial is testing

Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy

Who this might be right for
Geographic Atrophy Due to Age-Related Macular Degeneration
Theratocular Biotek Co. 31
Not applicableStudy completedNCT03451578
What this trial is testing

Alpha MSH in Ocular Disease

Who this might be right for
Advanced Dry Macular Degeneration
Duke University 54
Testing effectiveness (Phase 2)Study completedNCT01342926
What this trial is testing

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 191
Testing effectiveness (Phase 2)Active Not RecruitingNCT06018558
What this trial is testing

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

Who this might be right for
Geographic Atrophy
Ocugen 60
Not applicableLooking for participantsNCT05438732
What this trial is testing

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
VisionCare, Inc. 125
Not applicableStudy completedNCT03333954
What this trial is testing

Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular Degeneration
Science Corporation 5
Testing effectiveness (Phase 2)Study completedNCT01344993
What this trial is testing

Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration

Who this might be right for
Dry Age Related Macular Degeneration
Astellas Institute for Regenerative Medicine 13
Testing effectiveness (Phase 2)Looking for participantsNCT07174687
What this trial is testing

SGLT2 Inhibitors in Geographic Atrophy

Who this might be right for
Retinal DegenerationRetinal DiseasesEye Diseases+2 more
Washington University School of Medicine 70
Not applicableStudy completedNCT07428798
What this trial is testing

Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age Related Macular Degeneration
Marmara University Pendik Training and Research Hospital 14
Not applicableActive Not RecruitingNCT01115387
What this trial is testing

GARM II: A Study on the Genetics of Age-related Maculopathy

Who this might be right for
Age-related Macular DegenerationAge-related Maculopathy
University of California, Los Angeles 603
Testing effectiveness (Phase 2)Looking for participantsNCT07029945
What this trial is testing

The Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Biojiva LLC 152
Large-scale testing (Phase 3)Active Not RecruitingNCT06510816
What this trial is testing

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Annexon, Inc. 659
Testing effectiveness (Phase 2)Study completedNCT00940407
What this trial is testing

Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration

Who this might be right for
Nonexudative Age-related Macular Degeneration
Merry, Graham, M.D. 18
Not applicableEnrolling By InvitationNCT07529041
What this trial is testing

Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging Diagnostic Quality

Who this might be right for
Retinal DystrophiesGeographic AtrophyBlindness
University Medical Center Goettingen 22
Testing effectiveness (Phase 2)Looking for participantsNCT07158775
What this trial is testing

Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD

Who this might be right for
Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
Bionic Sight LLC 40
Testing effectiveness (Phase 2)Ended earlyNCT01577381
What this trial is testing

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Maculopathy
Pfizer 10
Testing effectiveness (Phase 2)Looking for participantsNCT07392255
What this trial is testing

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Next Page